Meet Mark Luttmann, one of our respiratory pioneers. Mark was on the drug discovery team for a key component of several of our COPD medications.
Meet Jamie Kinghorn, a site communications manager at our Montrose site in the UK. Here Jamie explains how he’s controlled his asthma from a very young age; and how managing his asthma enabled him to climb Mount Kenya to support Save the Children.
Paul Irving has been a friendly voice to patients for 16 years at our US Patient Response Center. Here, he tells about his passion for helping patients and reveals what it’s like to be at the other end of the line.
There are over 36 million people living with HIV around the world with an estimated 70 percent who are not adequately treating the virus.
See how Steve and his team refined their scientific focus in order to deliver our first biologic respiratory medicine.
Everyone talks about “leadership.” Business schools teach courses on it and war metaphors abound. Great leaders are often described as near-mythical creatures - like unicorns.
As a healthcare company, we focus on how we can best support the wellbeing of patients, consumers, and our employees.
We all want the time and energy to invest in the things that matter most. That is why GSK is expanding our paid parental leave benefit in 2017.
GSK's David Lynch reflects on his career, the role of engineering in healthcare, and the path to leadership in the profession.
Priscilla is quick to tell you she’s not looking forward to this school year; how her sister drives her nuts; and how doubling up on algebra and geometry is going to make this year tougher than any before.
When a company is as old as GSK (300 years this year!), the archives swell with items and documents related to our corporate heritage.
We are incredibly proud to be a Founding Donor of The National Museum of African American History and Culture in the Smithsonian Institution.
GSK medic, Emma Hilton, tells us about her career in science and how she makes hard work easier.
I was born and raised in Mexico and grew up loving both science and people. This love drove me to study Chemical Engineering which eventually helped me become an engineer, a line manager, and, currently, the director of the Future Leaders Program in Global Manufacturing and Supply at GSK.
Professor Christopher Cooper joined GSK as a Global Medical Expert, Scientific Faculty, GSK Global Respiratory Franchise. Here he explains why he chose to move from academia to industry.
Andy Dundon leads our Research and Development (R&D) Device Engineering team in Ware, UK. His team focuses on ways to improve the design of our drug delivery devices, including through the use of digital technologies.
Dr. Murray Stewart is our Chief Medical Officer. In this role, he is the most senior physician at GSK, and has overall responsibility for patient well-being across vaccines, pharmaceutical and consumer medicines. He also oversees medical ethics and integrity.
Today too many people suffer unnecessarily because of the poor management of their asthma and COPD.
Every day, Rajendra rides his motorcycle 30 kilometres to and from the area he covers, and also uses it to travel to meet healthcare professionals.
In 2015, GSK Vaccines sent two vaccine manufacturing teams to South America and Africa to better understand the impact of their daily work.
Laura is a scientist and a mom. Here she describes what motivates her to fight against malaria.
Not everyone gets to live their dream job, but I feel extremely lucky and grateful that I do. I lead GSK’s global employee volunteering efforts, including PULSE, our flagship program.
GSK is targeting a carbon neutral value chain by 2050 and has ambitious goals to reduce carbon, water and waste in the meantime.
Tracy has been a driving force behind GSK’s progress in the US and around the world. She also plays an important role in a number of diversity organizations.
George, GSK Medical Science Liaison Director, has his Pharm.D., is based in Dallas, TX, has worked for GSK for fourteen years, and manages of a team of eight other Medical Science Liasons.
Linda, GSK Community Partnership Representative, 26-year employee of GSK, the second in a three-generation family of GSK’ers, and a Philadelphia native.
Our responsible business reforms are taking hold here in the US market and with our US employees.
As a physician, a senior executive, a researcher and a parent, I play many roles – but I don’t often stop to think about my gender.
Rare Disease Day on 29th February holds personal significance for two colleagues working in our Rare Disease Unit; Jessica Imrie and Julie Venners Christensen both have children with rare disorders.
A mechanical engineering graduate on a GSK Future Leaders Programme is helping to develop user-friendly devices to administer treatments safely.
PULSE volunteer, Mizanul Islam shares his experience of working with Save the Children in Bungoma County, Kenya for six months in 2015.
Allan Pamba recalls his experiences as a doctor in Kenya and why he decided to work for ‘the enemy' - a pharmaceutical company.
Simon Wright, Head for Child Survival at Save the Children, talks about how we’re working together to make sure the health needs of the world’s poorest children are at the top of everyone’s agenda.
In the world of business—and scientific research—war metaphors abound. “Hitting our targets.” “Fighting cancer.” What we don’t see are many comparisons to peacekeeping.
The PULSE Volunteer program is GSK’s flagship skills-based volunteering initiative. Launched in 2009, PULSE serves as a matchmaker for GSK and the non-profit sector – connecting the skills of our high-performing employees with the pressing needs of our non-profit partners.
For some, breathing easy sounds simple – it just happens. But for Sarah and for millions of others like her, breathing can be a daily struggle.
In our opinion, being transparent is not a path to failure — it is a source of strength.
How do doctors and insurers in the US get the info they need to make decisions about medicines for patients?
Martin Andrews leads our Rare Diseases Unit to help advance the treatment of patients affected by rare diseases. He was appointed Senior Vice President, GSK Rare Diseases in November 2013.